BRCA-Associated Ovarian Cancer: From Molecular Genetics to Risk Management | Zendy

Giulia Girolimetti | Zendy; Anna Myriam Perrone | Zendy; Donatella Santini | Zendy; Elena Barbieri | Zendy; Flora Guerra | Zendy; Simona Ferrari | Zendy; Claudio Zamagni | Zendy; Pierandrea De Iaco | Zendy; Giuseppe Gasparre | Zendy; Daniela Turchetti | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

BRCA-Associated Ovarian Cancer: From Molecular Genetics to Risk Management

Author(s) -

Giulia Girolimetti,

Anna Myriam Perrone,

Donatella Santini,

Elena Barbieri,

Flora Guerra,

Simona Ferrari,

Claudio Zamagni,

Pierandrea De Iaco,

Giuseppe Gasparre,

Daniela Turchetti

Publication year - 2014

Publication title -

biomed research international

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.772

H-Index - 126

eISSN - 2314-6141

pISSN - 2314-6133

DOI - 10.1155/2014/787143

Subject(s) - ovarian cancer , asymptomatic , asymptomatic carrier , mutation , medicine , brca mutation , cancer , epidemiology , genetics , identification (biology) , oncology , gene , bioinformatics , gynecology , biology , botany

Ovarian cancer (OC) mostly arises sporadically, but a fraction of cases are associated with mutations in BRCA1 and BRCA2 genes. The presence of a BRCA mutation in OC patients has been suggested as a prognostic and predictive factor. In addition, the identification of asymptomatic carriers of such mutations offers an unprecedented opportunity for OC prevention. This review is aimed at exploring the current knowledge on epidemiological and molecular aspects of BRCA-associated OC predisposition, on pathology and clinical behavior of OC occurring in BRCA mutation carriers, and on the available options for managing asymptomatic carriers.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research